Wenxin Qin

13PUBLICATIONS
58CO-AUTHORS
Predictive and prognostic markersCancer diagnosisCancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Mar 25, 2025
PRMT1-mediated modification of H4R3me2a promotes liver cancer progression by enhancing the transcriptional activity of SOX18.

Jing Ling, Siying Wang, Chenhe Yi

|Feb 06, 2025
Hepatocellular carcinoma: signaling pathways and therapeutic advances.

Jiaojiao Zheng, Siying Wang, Lei Xia

|Dec 09, 2024
Efficacy and safety of lenvatinib plus gefitinib in lenvatinib-resistant hepatocellular carcinomas: a prospective, single-arm exploratory trial.

Yaoping Shi, Dan Cui, Lei Xia

|Mar 27, 2024
Paradoxical Activation of Oncogenic Signaling as a Cancer Treatment Strategy.

Matheus Henrique Dias, Anoek Friskes, Siying Wang

|Feb 09, 2023
Combating inconsistent evaluation of intra-tumor immune status by a novel transcriptomic signature in hepatocellular carcinoma.

Linmeng Zhang, Ning Tang, Chen Yang

|Nov 22, 2022
cFLIP suppression and DR5 activation sensitize senescent cancer cells to senolysis.

Liqin Wang, Haojie Jin, Fleur Jochems

Pageof 3

Frequent Collaborators

7 joint publications

René Bernards

5 joint publications

Cun Wang

3 joint publications

Roderick L Beijersbergen

3 joint publications

Haojie Jin